Humoral and cell-mediated immunity six months post BNT162b2 vaccination

By | November 2, 2021
A recent study has evaluated vaccine-induced humoral and cellular immunity against SARS-CoV-2 six months post BNT162b2 (Pfizer-BioNTech) vaccination.